Discovery of a novel PARP1/2 inhibitor through pharmacophore-guided virtual screening and biological validation
Journal of Pharmaceutical Analysis · 2026-08 · 101747
DOI: 10.1016/j.jpha.2026.101747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-08. Verfasst von Natàlia DeMoya-Valenzuela und 9 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CRIS Cancer Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- CRIS Cancer Foundation
Zitieren
APA
DeMoya-Valenzuela, N., Privat, C., Díaz-Tejeiro, C., Gancarski, P., Poyatos-Racionero, E., Nieto-Jiménez, C., Rodríguez-Olmedo, P., Segura, P. P., Paniagua-Herranz, L., & Ocana, A. (2026). Discovery of a novel PARP1/2 inhibitor through pharmacophore-guided virtual screening and biological validation. Journal of Pharmaceutical Analysis, 101747. https://doi.org/10.1016/j.jpha.2026.101747
Vancouver
DeMoya-Valenzuela N, Privat C, Díaz-Tejeiro C, Gancarski P, Poyatos-Racionero E, Nieto-Jiménez C, et al. Discovery of a novel PARP1/2 inhibitor through pharmacophore-guided virtual screening and biological validation. Journal of Pharmaceutical Analysis. 2026:101747. doi:10.1016/j.jpha.2026.101747
BibTeX
@article{DeMoyaValenzuela2026,
author = {DeMoya-Valenzuela, Natàlia and Privat, Cristian and Díaz-Tejeiro, Cristina and Gancarski, Pawel and Poyatos-Racionero, Elisa and Nieto-Jiménez, Cristina and Rodríguez-Olmedo, Pablo and Segura, Pedro Pérez and Paniagua-Herranz, Lucía and Ocana, Alberto},
title = {Discovery of a novel PARP1/2 inhibitor through pharmacophore-guided virtual screening and biological validation},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
pages = {101747},
doi = {10.1016/j.jpha.2026.101747}
}
EUVIMED